Legal & General Group’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-60,868
| Closed | -$1.78M | – | 3300 |
|
|
2017
Q3 | $1.78M | Buy |
60,868
+973
| +2% | +$27.3K | ﹤0.01% | 1640 |
|
|
2017
Q2 | $1.57M | Buy |
59,895
+4,892
| +9% | +$120K | ﹤0.01% | 1650 |
|
|
2017
Q1 | $1.29M | Buy |
55,003
+88
| +0.2% | +$2.17K | ﹤0.01% | 1705 |
|
|
2016
Q4 | $1.38M | Buy |
54,915
+24,726
| +82% | +$624K | ﹤0.01% | 1617 |
|
|
2016
Q3 | $844K | Buy |
30,189
+24,456
| +427% | +$627K | ﹤0.01% | 1465 |
|
|
2016
Q2 | $140K | Hold |
5,733
| – | – | ﹤0.01% | 1926 |
|
|
2016
Q1 | $125K | Sell |
5,733
-270
| -4% | -$7.19K | ﹤0.01% | 1929 |
|
|
2015
Q4 | $208K | Hold |
6,003
| – | – | ﹤0.01% | 1730 |
|
|
2015
Q3 | $169K | Buy |
6,003
+1,542
| +35% | +$51.8K | ﹤0.01% | 1782 |
|
|
2015
Q2 | $150K | Hold |
4,461
| – | – | ﹤0.01% | 1872 |
|
|
2015
Q1 | $125K | Hold |
4,461
| – | – | ﹤0.01% | 1898 |
|
|
2014
Q4 | $93K | Hold |
4,461
| – | – | ﹤0.01% | 2027 |
|
|
2014
Q3 | $110K | Buy |
+4,461
| New | +$118K | ﹤0.01% | 1830 |
|
Legal & General Group's PMC Position: Q4 2017 in Review
Legal & General Group sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 60,868 shares — an estimated $1.78M sold.
Legal & General Group first reported a position in PMC in Q3 2014 and held it in 13 quarters. The position peaked at $1.78M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Legal & General Group reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Legal & General Group sold 60,868 PharMerica Corporation shares in Q4 2017, an estimated $1.78M.
- Legal & General Group first reported a position in PharMerica Corporation in Q3 2014 and held it in 13 quarters.
- Legal & General Group's PharMerica Corporation position peaked at $1.78M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Legal & General Group's 13F filing for Q4 2017, filed 13 Feb 2018.